Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$395,811
+$92,287 QoQ
Shares Held
330
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#3,944
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WHITE PINE CAPITAL LLC holds $15,035,002 across 8 Drug Manufacturers - General names. LLY ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,431 | $6,458,711 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,201 | $4,394,828 | |
| 3 | ABBV |
AbbVie Inc.
|
5,717 | $1,438,625 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
19,980 | $1,151,247 | |
| 5 | AMGN |
Amgen Inc
|
1,134 | $410,644 | |
| 6 | PFE |
Pfizer Inc
|
16,582 | $399,294 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
330 | $395,811 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,054 | $385,842 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $395,811 | 330 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $303,524 | 330 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $354,644 | 330 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $251,790 | 330 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $257,244 | 330 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $272,550 | 330 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $254,760 | 330 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $292,360 | 330 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $298,775 | 330 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||